Sehen wir einmal davon ab, dass sich in der Regel im Zuge mutationsbedingter Virenentwicklung tatsĂ€chlich die âleichteren Variantenâ durchsetzen, weil ihre Wirte sich besserer Gesundheit erfreuen und sie deshalb weitergeben können â âausschlieĂenâ kann man ĂŒblicherweise gar nichts, keine unangenehmen Varianten und auch keine aufschlagenden Kometen. Aber deshalb laufen wir nicht auf Jahre hinaus mit einem Helm auf dem Kopf durch die Welt und deshalb mĂŒssen wir auch nicht zu MaĂnahmen greifen, die man nur noch mit Begriffen des Strafrechts oder â bei unterstellter SchuldunfĂ€higkeit â der Psychiatrie charakterisieren kann.
Archiv: SARS II variants (incomplete list): D614D / D614G / 20A.EU1 / VUI 202012/01 (B.1.1.7 / B.1.351) / 501.V2.
RNA for Modernaâs Omicron Booster Manufactured by CIA-Linked Company
The firm only acquired its first commercial manufacturing plant in March 2021, located in Boston, MA and purchased from Sanofi, followed shortly thereafter by the acquisition of another separate plant located in Mississauga, Ontario, Canada. Makeovers were announced for the plants, but little is publicly known about their progress. Prior to the acquisitions, the company had been subleasing a Bay area facility in Fremont, California. Reporters were puzzled at the time as to why a company with roughly 700 employees at the time had acquired a total of 599,00 square feet of manufacturing space after having only emerged from stealth less than 6 months prior.
In April 2021, National Resilience acquired Ology Bioservices Inc., which had received a $37 million contract from the US military the previous November to develop an advanced anti-COVID-19 monoclonal antibody treatment. This acquisition also provided National Resilience with its first Biosafety Level 3 (BSL-3) laboratory and the ability to manufacture cell and gene therapies, live viral vaccines and vectors and oncolytic viruses.
Despite being in the earliest stages of developing its ârevolutionaryâ manufacturing capabilities, National Resilience entered into a partnership with the Government of Canada in July of last year.
What Is the Origin of COVID-19 Variants Like Omicron?
(July 2, 2022)
According to recent research from Tel Aviv University, immunosuppressed chronic COVID-19 patients are thought to be the source of several SARS-CoV-2 variants. The researchers hypothesize that a compromised immune reaction, particularly in the lower airways of these chronic patients, may delay complete recovery from the virus and cause the virus to evolve often during the course of prolonged infection.
SĂŒdafrika: Neuinfektions-, Hospiz- und Todesraten bisher weit unter Werten voran gegangener Wellen
Nach Johns Hopkins Daten liegt am 4. Dezember die Tagesinzidenz von Deutschland bei 676, von SĂŒdafrika bei 109 und der Mittelwert der afrikanischen LĂ€nder bei 8 tĂ€glichen Neuinfektionen je 1.000.000 Einwohner.
Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections
(August 25, 2021)
Results:
SARS-CoV-2-naĂŻve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant (P<0.001) for symptomatic disease as well. When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naĂŻve vaccinees had a 5.96-fold (95% CI, 4.85 to 7.33) increased risk for breakthrough infection and a 7.13-fold (95% CI, 5.51 to 9.21) increased risk for symptomatic disease. SARS-CoV-2-naĂŻve vaccinees were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.
Necessity of COVID-19 vaccination in previously infected individuals
(19.06.2021)
Results Among the 52238 included employees, 1359 (53%) of 2579 previously infected subjects remained unvaccinated, compared with 20804 (42%) of 49659 not previously infected. The cumulative incidence of SARS-CoV-2 infection remained almost zero among previously infected unvaccinated subjects, previously infected subjects who were vaccinated, and previously uninfected subjects who were vaccinated, compared with a steady increase in cumulative incidence among previously uninfected subjects who remained unvaccinated. Not one of the 1359 previously infected subjects who remained unvaccinated had a SARS-CoV-2 infection over the duration of the study.
A 1 to 1000 SARS-CoV-2 reinfection proportion in members of a large healthcare provider in Israel: a preliminary report
(March 8, 2021)
In this descriptive preliminary report, we conducted a large-scale assessment on the country level of the possible occurrence of COVID-19 reinfection within the members of a large healthcare provider in Israel. Out of 149,735 individuals with a documented positive PCR test between March 2020 and January 2021, 154 had two positive PCR tests at least 100 days apart, reflecting a reinfection proportion of 1 per 1000.
81 Research Studies Confirm Natural Immunity to COVID âEqualâ or âSuperiorâ to Vaccine Immunity
(19.10.2021)
Iâve benefited from the input of many to put this together, especially my co-authors:
Dr. Harvey Risch, M.D., Ph.D. (Yale School of Public Health)
Dr. Howard Tenenbaum, Ph.D. ( Faculty of Medicine, University of Toronto)
Dr. Ramin Oskoui, M.D. (Foxhall Cardiology, Washington)
Dr. Peter McCullough, M.D. (Truth for Health Foundation, Texas)
Dr. Parvez Dara, M.D. (consultant, Medical Hematologist and Oncologist)
Evidence on natural immunity versus COVID-19 vaccine induced immunity as of Oct. 15:
New Covid variant vaccine in trials to act as booster against âall new strainsâ
(10.06.2021)
Although the new vaccine variants shows considerable promise, Prof Gilbert said there was no guarantee it would be mass-produced since existing jabs are proving effective against new strains â so it may make more sense to carry on producing those rather than manufacturing different ones.
Covid Cases Are Soaring in Britain Again. Why?
The countryâs full-speed approach to lifting restrictions has certainly contributed to a spike in infections. But thatâs only part of the picture.
New Covid variant vaccine in trials to act as booster against âall new strainsâ
(10.06.2021)
Although the new vaccine variants shows considerable promise, Prof Gilbert said there was no guarantee it would be mass-produced since existing jabs are proving effective against new strains â so it may make more sense to carry on producing those rather than manufacturing different ones.
PM Boris Johnson: The Oxford vaccine shows why we and the world need Britain to be global
(16.03.2021)
The objective of Global Britain is not to swagger or strike attitudes on the world stage. It is to use the full spectrum of our abilities, now amplified by record spending on both defence and science, to engage with and help the rest of the world. That is how we serve the British interest, and I mean the economic interest of people up and down the country. And as the vaccine programme begins to inspire a new global hope, we want to use this moment to heal, both literally and figuratively.
New Covid vaccines could be made in 40 DAYS if they need updating to tackle mutated variants, taskforce chief says
(17.02.2021)
Dr Dix added: ‚I think 40 days would be a real stretch but we would aim for something as good as that.
‚But certainly within 60 days and then, after that, we would start the manufacturing.‘
Manufacturing vaccines takes different amounts of time depending on the type of jab.
But the Oxford/AstraZeneca team, which uses more traditional viral vector technology, says that while it can make a new formulation in days, it takes much longer to produce.
(09.02.2021)
It expects to have a vaccine designed to address the variant discovered in South Africa ready by autumn.
Covid vaccines can be âtweakedâ to deal with new variants of virus, says Oxford prof
(30.12.2020)
Professor Andrew Pollard said it was „entirely possible“ to adapt the jab to protect people from other strains.
But he added that there is no evidence so far to suggest that the vaccines won‘t work against a new mutation.
It comes as a variant in the South East has been blamed for a rise in cases, with scientists warning it‘s more contagious and can spread more rapidly.
Oxford vaccine: How did they make it so quickly?
(23 November 2020)
The virus from chimps is genetically modified so it cannot cause an infection in people. It can then be modified again to contain the genetic blueprints for whatever you want to train the immune system to attack. This target is known is an antigen.
ChAdOx1 is in essence a sophisticated, microscopic postman. All the scientists have to do is change the package.
„We drop it in and off we go,“ said Prof Gilbert.
All theories on origins of Covid-19 outbreak still âon the tableâ, says WHO
(25.08.2021)
âThe current situation is that all of the hypotheses regarding to the origins of the virus are still on the table,â Michael Ryan, the head of the WHOâs health emergencies programme, in response to a question about the laboratory leak theory. âSome are more likely than others based on the current analysis, but all of those hypotheses require further elucidation and further inquiry and we will go and look where all of those leads take the WHO.â
Biden receives inconclusive intelligence report on covid origins
The report falls short of concluding whether the coronavirus jumped from animal to human, or might have accidentally escaped from a lab in China
Bericht der US-Geheimdienste: Corona-Ursprung bleibt ungeklÀrt
Rund drei Monate lang hatten US-Geheimdienste im Auftrag von US-PrĂ€sident Joe Biden zum Ursprung des Coronavirus recherchiert. Jetzt liegt ihr Bericht vor – doch zu einem eindeutigen Ergebnis sind sie nicht gekommen. Ob das Virus aus einem Labor stamme oder von einem Tier auf den Menschen ĂŒbergesprungen sei, sei offen, hieĂ es. Beides seien „plausible Hypothesen“.
Angeblicher Experte in China: Der mysteriöse Wilson Edwards
Der Fall zeigt, wie hoch politisiert die Suche nach dem Ursprung des Corona-Virus gerade auf chinesischer Seite ist. FĂŒr die USA und die Weltgesundheitsorganisation ist die Laborthese nicht vom Tisch. Solange diese These aber weiter im Spiel ist, blockt China weitere Untersuchungen ab – und sucht UnterstĂŒtzung notfalls auch bei Phantom-Forschern.
Israeli Data Suggests Possible Waning in Effectiveness of Pfizer Vaccine
(today)
The new numbers still show overwhelmingly strong protection against severe disease but diminished effectiveness against infection.
Covid-19: Wie Massenhysterie in Wohlfahrtsstaaten entsteht
Hinsichtlich der Covid-19-Krise gibt es mehrere Studien, welche die negativen psychologischen Auswirkungen von staatlich verordneten Lockdowns untersuchen (1) (2) (3) (4). Es gibt auch Studien, die den Beitrag digitaler Medien und des Internets zu Angst (5) (6), emotionaler Ansteckung (7) (8), AngstĂŒbertragungen (9) (10) und Nocebo-Effekten (11) (12) untersuchen. Nach unserem Wissen gibt es jedoch keine Studie, die analysiert, wie verschiedene politische Institutionen und der Staat die Entstehung und Ausbreitung von Massenhysterien beeinflussen. Das Zusammenspiel von Medien, Wissenschaft, Politik und Ăffentlichkeit ist eine wesentliche ForschungslĂŒcke (13). Aufbauend auf der Psychologie im Zusammenhang mit dem PhĂ€nomen der kollektiven Panik entwickeln wir eine politische Ăkonomie der Massenhysterie.
Up to 40% of ‚Covid hospital patients‘ infected with Delta variant may have been admitted for a different illness, official figures suggest
Four out of 10 patients hospitalised with the Indian Covid variant in England may have been admitted for something else, MailOnline analysis of official data suggests.
Public Health England‘s fortnightly report on the ‚Delta‘ strain showed a total of 1,904 people had spent at least one night in hospital with the mutant virus by June 21.
But the agency admits 739 (39 per cent) of these patients may have gone to hospital for a different condition or injury and tested positive through routine NHS testing.
Delta-Ausbreitung: Regierung hĂ€lt an Ăffnungen fest
Nach einer langen Phase des RĂŒckgangs steigt die Zahl der CoV-Neuinfektionen in Ăsterreich und vielen anderen EU-LĂ€ndern wieder. Die Ampelkommission und das CoV-Prognosekonsortium orten aufgrund der Verbreitung der hochansteckenden Delta-Variante eine âhohe Wahrscheinlichkeitâ fĂŒr eine vierte Welle in Ăsterreich.
Sack him Boris! ‚Useless‘ Hancock told to go after claim he withheld positive vaccine news
(20.06.2021)
A study by Public Health England (PHE) was released on June 14 and concluded the vaccines offered âsignificant protection against hospitalisation from the delta variantâ. The Health Secretary is alleged to have known about the findings on June 10 – three days before the Prime Minister ultimately decided to delay the June 21 âFreedom Dayâ by four weeks.
Exclusive: Matt Hancock kept Boris Johnson in dark over Covid vaccines success
(19.06.2021)
Matt Hancock failed to tell Boris Johnson about a major Public Health England (PHE) study showing the effectiveness of vaccines against the Indian or delta variant during a key meeting to decide whether to extend Covid restrictions, The Telegraph can disclose.
The Telegraph understands that the Health Secretary had known about the PHE data three days before the „quad“ of four senior ministers, led by the Prime Minister, met last Sunday to decide whether to postpone the planned June 21 reopening until July 19.